AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lexicon Pharmaceuticals, Inc.

$1.42 +$0.28 (+24.56%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$1.48
Day Range
$1.38$1.50
Year Range
$1.10$2.68
Market Cap
631.84M
AVG Volume
3.17M
Trailing/Forward PE
-9.44/-
PEG ratio
-9.01
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LXRX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q241.47M
26 Q169.64M
25 Q449.8M
25 Q370.86M
25 Q258.43M
25 Q131.21M
24 Q431.08M
24 Q35.23M
24 Q23.64M
24 Q12.31M
Net Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LXRX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-61.12M
26 Q1-26.09M
25 Q4-50.34M
25 Q3-68.58M
25 Q2-120.62M
25 Q1-177.3M
24 Q4-200.4M
24 Q3-216.39M
24 Q2-202.11M
24 Q1-193.58M
Operating Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
LXRX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-54.5M
26 Q1-24.23M
25 Q4-48.91M
25 Q3-66.87M
25 Q2-118.37M
25 Q1-177.46M
24 Q4-197.12M
24 Q3-211.12M
24 Q2-197.06M
24 Q1-185.94M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: LXRX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Lexicon Pharmaceuticals, Inc.
LXRX
Stockpicker

Video analysis: LXRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: LXRX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.